19

2026

-

10

Leda Tang — a pharmaceutical product for the treatment of diabetes, manufactured by Hubei Guangchen Pharmaceutical Co., Ltd.

Author:


LE DA TANG is a pharmaceutical brand dedicated to the treatment of diabetes, with its flagship product being “LE DA TANG® Linagliptin–Metformin Extended-Release Tablets (I).” This combination antidiabetic formulation contains the DPP‑4 inhibitor linagliptin and the biguanide metformin hydrochloride. Manufactured by Hubei Guangchen Pharmaceutical Co., Ltd., it is the first domestically approved extended-release formulation of its kind, indicated for glycemic control in adult patients with type 2 diabetes who are suitable for treatment with both linagliptin and metformin.

Product Overview

LE DA TANG is a pharmaceutical company specializing in the treatment of diabetes, with its flagship product being “LE DA TANG® Linagliptin–Metformin Extended-Release Tablets (I).” This product is a combination antidiabetic formulation containing the dipeptidyl peptidase‑4 (DPP‑4) inhibitor linagliptin and the biguanide drug metformin hydrochloride. Manufactured by Hubei Guangchen Pharmaceutical Co., Ltd., it is the first domestically approved extended-release formulation of its kind, indicated for glycemic control in adult patients with type 2 diabetes who are suitable candidates for treatment with both linagliptin and metformin.

Product Information

Chinese name Leda Tang
Field of affiliation Pharmaceuticals and Healthcare: Diabetes Treatment
Core product Lida Tang® Linagliptin-Metformin Extended-Release Tablets (I)
Manufacturing enterprise Hubei Guangchen Pharmaceutical Co., Ltd.
Marketing Authorization Holder Hubei Guangchen Pharmaceutical Co., Ltd.
Approval Number National Drug Approval Number H20255813
Product Specifications Each tablet contains 5 mg of linagliptin and 1,000 mg of metformin hydrochloride.

Product Background

Ledar Tang is a pharmaceutical product dedicated to the treatment of diabetes. Its core product, “Ledar Tang® Linagliptin–Metformin Extended-Release Tablets (I),” is manufactured by Hubei Guangchen Pharmaceutical Co., Ltd. As the marketing authorization holder for this product, the company leverages its well-established production and quality management systems to provide patients with a standardized, reliable option for glycemic control.

Product Positioning and Philosophy

Leda Tang is dedicated to the treatment of chronic diseases, particularly diabetes, and upholds the principles of compliance, professionalism, and trustworthiness. It adheres to legal and regulatory requirements in disseminating product information, relying exclusively on drug package inserts approved by the national drug regulatory authorities as the sole source of official drug information, and advocates for the scientific and standardized use of medications under the guidance of healthcare professionals.

Core product

Leda Tang® is a linagliptin–metformin extended-release tablet (I).

Generic Name: Linagliptin and Metformin Extended-Release Tablets (I)

English Name: Linagliptin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Indications: In combination with dietary management and exercise, this product is indicated for adult patients with type 2 diabetes who are suitable for treatment with linagliptin and metformin, to improve glycemic control in these patients.

Specification: Each tablet contains 5 mg of linagliptin and 1,000 mg of metformin hydrochloride.

Directions and Dosage: Take one tablet once daily with food.

 

Related News

Hubei Guangchen Pharmaceutical Co., Ltd. Has Been Recognized as a Credible Enterprise Abiding by Contracts for the 15th Yichang Session (2024–2025)

2026-08-03